Health News

Completely New Way to Treat Childhood Cancer
Scientists have entered a brave new world when it comes to treating childhood leukemia. New therapies now being tested may completely change the way one type of blood cancer is treated in children.
Teens Can Control the Major Cramps
Cramps are completely normal during a teenage girl's period. Severe cramps that occur at other times of the month could mean a more serious condition that needs treatment.
Lowering Hypertension is Not Easy
African Americans often develop high blood pressure at earlier ages than others. A common medication may be a solution to keep pressure under control.
Smoking Away a Healthy Smile
Of course good oral hygiene is key in preventing tooth loss, but other lifestyle factors are important too. Healthy teeth may reflect healthy lifestyle choices.
Bird Flu Cases Grow in Number
Could a new outbreak of bird flu be about to strike in China? More information is coming out about the illness.
Following the Rx to the Letter – or Not
Patients may not always follow the instructions their doctors provide for prescription medications. In fact, more than half of Americans in a recent study did not.
Who Needs Breast Cancer Gene Testing
The risk of breast cancer can be such that women may have both breasts removed to avoid the possibility. Would genetic testing affect this decision?
Reducing Relapse with New MS Medication
In most patients, multiple sclerosis (MS) attacks in spurts. That is, periods of debilitating symptoms are followed by periods with few or no symptoms. Researchers are currently testing a new medication to reduce these attacks.
Pfizer’s BOSULIF Receives Conditional Marketing Authorization From The European Commission
Pfizer Inc. announced today that the European Commission (EC) has granted conditional marketing authorization for BOSULIF ® (bosutinib) in the European Union (EU) for the treatment of adult patients with chronic phase (CP), accelerated phase (AP) and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Rich Products Corporation Recalls Products for E. Coli Risk
Rich Products Corporation of Buffalo, New York, has announced a voluntary recall of certain Farm Rich ® and Market Day ® products.
<< first774775776777778779780781782last >>

REFINE